Liposarcoma staging: Difference between revisions
Jump to navigation
Jump to search
Line 71: | Line 71: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Table adapted from National Cancer Institute <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small> | | style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Table adapted from National Cancer Institute <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small> | ||
|} | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 500px;" align=center | |||
|valign=top| | |||
|+ | |||
| style="background: #4479BA; font-weight: bold; width: 100px;" | {{fontcolor|#FFF|Stages}} | |||
| style="padding: 5px 5px; background: #4479BA; width: 100px;" | {{fontcolor|#FFF|Primary Tumor (T)}} | |||
| style="padding: 5px 5px; background: #4479BA; width: 100px;" | {{fontcolor|#FFF|Lymph Node (N)}} | |||
| style="padding: 5px 5px; background: #4479BA; width: 100px;" | {{fontcolor|#FFF|Metastasis (M)}} | |||
| style="padding: 5px 5px; background: #4479BA; width: 100px;" | {{fontcolor|#FFF|Histopathological Grading}} | |||
|- | |||
| style="background: #4479BA; font-weight: bold; width: 100px;" | {{fontcolor|#FFF|Stage IA}} | |||
| style="padding: 5px 5px; background: #DCDCDC; width: 100px;" | T1a, T1b | |||
| style="padding: 5px 5px; background: #F5F5F5; width: 100px;" | N0 | |||
| style="padding: 5px 5px; background: #DCDCDC; width: 100px;" | M0 | |||
| style="padding: 5px 5px; background: #F5F5F5; width: 100px;" | Low grade | |||
|- | |||
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF|Stage IB}} | |||
| style="padding: 5px 5px; background: #DCDCDC;" | T2a, T2b | |||
| style="padding: 5px 5px; background: #F5F5F5;" | N0 | |||
| style="padding: 5px 5px; background: #DCDCDC;" | M0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Low grade | |||
|- | |||
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF|Stage IIA}} | |||
| style="padding: 5px 5px; background: #DCDCDC;" | T1a, T1b | |||
| style="padding: 5px 5px; background: #F5F5F5;" | N0 | |||
| style="padding: 5px 5px; background: #DCDCDC;" | M0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" | High grade | |||
|- | |||
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF| Stage IIB}} | |||
| style="padding: 5px 5px; background: #DCDCDC;" | T2a, T2b | |||
| style="padding: 5px 5px; background: #F5F5F5;" | N0 | |||
| style="padding: 5px 5px; background: #DCDCDC;" | M0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" | High grade | |||
|- | |||
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF| Stage III}} | |||
| style="padding: 5px 5px; background: #DCDCDC;" | Any T | |||
| style="padding: 5px 5px; background: #F5F5F5;" | N0, N1 | |||
| style="padding: 5px 5px; background: #DCDCDC;" | M0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" | High grade | |||
|- | |||
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF| Stage IV}} | |||
| style="padding: 5px 5px; background: #DCDCDC;" | Any T | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Any N | |||
| style="padding: 5px 5px; background: #DCDCDC;" | M1 | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Any grade | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" colspan=5|<small> Table adapted from National Cancer Institute <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small> | |||
|} | |} | ||
Revision as of 14:57, 19 September 2014
Liposarcoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Liposarcoma staging On the Web |
American Roentgen Ray Society Images of Liposarcoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
Staging
Primary Tumor (T) | |
---|---|
Tx | Tumor cannot be assessed. |
T0 | No evidence of primary tumor. |
T1 | Tumor ≤ 5 cm |
|
Superficial tumor (not invading the fascia) |
|
Deep tumor |
T2 | Tumor > 5 cm |
|
Superficial tumor (not invading the fascia) |
|
Deep tumor |
Table adapted from National Cancer Institute [1] |
Lymph Nodes (N) | |
---|---|
NX | Lymph nodes cannot be assessed. |
N0 | No regional lymph node involvement. |
N1 | Regional lymph node involvement. |
Table adapted from National Cancer Institute [1] |
Metastasis (M) | |
---|---|
M0 | No distant metastasis |
M1 | Distant metastasis |
Table adapted from National Cancer Institute [1] |
Stages | Primary Tumor (T) | Lymph Node (N) | Metastasis (M) | Histopathological Grading |
Stage IA | T1a, T1b | N0 | M0 | Low grade |
Stage IB | T2a, T2b | N0 | M0 | Low grade |
Stage IIA | T1a, T1b | N0 | M0 | High grade |
Stage IIB | T2a, T2b | N0 | M0 | High grade |
Stage III | Any T | N0, N1 | M0 | High grade |
Stage IV | Any T | Any N | M1 | Any grade |
Table adapted from National Cancer Institute [1] |
References